PsiOxus Therapeutics Appoints Dr Paolo Paoletti as Chairman of the Board

Former President of GSK Oncology Adds Depth of Cancer R&D Leadership OXFORD, UK – 7 January 2016 PsiOxus Therapeutics Ltd. (“PsiOxus”), the immuno-oncology company, has appointed Dr Paolo Paoletti, MD… read more →